Zachary Kanter

Route 53 Microsoft Office 365 Amazon AWS Rackspace MailGun Mimecast Outlook Marketo ADP WP Engine Atlassian Cloud Pantheon Greenhouse.io Google Font API Nginx Mobile Friendly SoundCloud Google Tag Manager Varnish Vimeo New Relic Typekit Remote AI Android Laravel React Native

biotechnology: pharmaceutical preparations health care transformative medicines fda approvals phase 3 trials immuno-dermatology therapeutics clinical development drug discovery biopharmaceuticals vant model agile companies capital allocation immunology autoimmune diseases strategic partnerships dermatology treatments rvt-3101 ulcerative colitis chronic inflammatory diseases molecular glues ai in drug discovery patient outcomes investigational drugs topical therapies clinical trials biomarker-driven innovative therapeutics pharmaceutical acquisitions biotech industry patient care health equity community health drug commercialization regulatory submissions biologics lead optimization preclinical studies healthcare technology stakeholder engagement market access venture capital governance diversity in pharma scientific innovation disruptive healthcare sustainability digital therapeutics global health solutions research & development healthcare innovation drug development pharmaceutical technology agile subsidiaries vants patient-centric healthcare technology platforms data sharing computational drug discovery rare diseases oncology neuroscience transformative therapies clinical efficacy social impact diverse pipeline rapid commercialization transparency market potential unmet medical needs healthcare solutions nimble execution collaborative science ethical standards diversity & inclusion health wellness & fitness hospital & health care environmental services renewables & environment biotechnology